◆ 会议时间:2025年8月3-6日
◆ 会议地点:奥地利 维也纳
◆ 会议简介:
2025年第18届国际行为医学大会(ICBM2025)将于2025年8月3-6日在奥地利维也纳举行,会议由国际行为医学学会(ISBM)主办。
国际行为医学学会(ISBM)旨在满足所有与整合心理社会行为科学和生物医学科学相关的健康相关学科的需求。行为医学可以定义为涉及与健康和疾病相关的心理社会、行为和生物医学知识的发展和整合宣以及将这些知识应用于预防、病因学、诊断、治疗和康复的跨学科领域。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
18th International Congress of Behavioral Medicine - ICBM 2025
Date:
August 3-6, 2025
Venue:
Vienna, Austria
Organized by:
International Society of Behavioral Medicine (ISBM)
摘要征文投稿:
September 9, 2024
Launch – Call for Abstracts
January 6, 2025
Deadline – Abstract Submission
January 13, 202
Launch – Late Breaking Abstracts Submission
March 31, 2025
Deadline – Late Breaking Abstracts Submission
April 15, 2025
Late Breaking Abstracts Selection and Notification
Deadline – Abstract Presenter Confirmation and Registration
点此提交摘要>>>Submit Abstract>>>
Guidelines
- All abstracts must be submitted through the ICBM 2025 Online Portal.
- Abstracts must be submitted and presented in English.
- Length: 250 words, not including title, authors, and affiliations
- Abstract Structure:
– Background
– Purpose
– Method
– Results
– Conclusion(s)
- Standard abbreviations may be used undefined, but non-standard abbreviations must be defined. Arabic numerals should be used for numbers except when beginning a sentence.
- Abstracts should disclose primary findings and should not include promissory statements such as “Results will be discussed.”
- No changes can be made to abstracts once the abstract submission deadline has passed.
- Presenting authors of accepted abstracts must be registered and paid participants. Registration must be received by the Secretariat by the Early Registration Deadline to ensure inclusion of the abstract in the meeting publications and in order to be scheduled for presentation.
- The submitting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
- The Scientific Committee will determine the presentation type of each accepted abstract, with consideration given to the author’s preference. The committee’s decision is final.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|